News
Curated Newsfeed
-
Swiss Cardio Technologies acquired by Abacus Medicine Group
With marketing approvals in 10 European Union countries and Switzerland, Swiss Cardio Technologies commercializes its cardiovascular solution, Cardioplexol in multiple regions. The scale-up has now…
startupticker.ch
-
Johnson & Johnson acquires Obaris
Only a year after its incorporation, OBaris AG was acquired by Johnson & Johnson, marking the beginning of a new phase of innovation in drug…
startupticker.ch
-
Flybotix secures close to USD 10 million to speed up global deployment
Flybotix, a global robotics company specializing in drone-based solutions for the inspection of confined-space of industrial and civilian assets, has raised close to USD 10…
startupticker.ch
DTN Highlights
-
Read more: All Eyes on SwitzerlandThe number of exits in Switzerland is rising again. Swiss technology companies are no longer being acquired solely for their technology and team, but increasingly…
-
Read more: Decoding the 2025 Top 100 Swiss Startup AwardLast night, the Swiss innovation ecosystem gathered under the bright lights of the ZSC Swiss Life Arena in Zürich, a major ice hockey stadium. The…
-
Read more: Into the Web with DTN’s Spider Analysis: Where We’re Strong, Where We’re Slow, and What To Do About ItOur new spider graph maps Switzerland’s position across four pillars of deep tech: Innovation & IP, Academia, Ecosystem, and Capital & Investment. A clear picture…
-
Spanish travel-tech unicorn acquires Yokoy
Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of…
startupticker.ch
-
AB2 Bio signs USD 600 million agreement with Nippon Shinyaku
AB2 Bio Ltd., developing therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18, has entered into an option and licensing…
startupticker.ch
-
ZuriQ secures $4.2M seed funding to break quantum computing's scaling barrier
Quantum computing startup ZuriQ has today announced the closing of its $4.2 million seed funding round to commercialize a radical new architecture that will enable scaling…
startupticker.ch
-
Transmutex receives $4 million grant to enable nuclear waste transmutation
Geneva-based startup Transmutex has received more than $4.2 million from the U.S. Department of Energy Advanced Research Projects Agency-Energy as part of the NEWTON Program.…
startupticker.ch
-
Tech Tour Growth Top 50 showcases Swiss deeptech companies
Switzerland is a hub of innovation, home to numerous trailblazing startups, including six that have earned a spot in the Tech Tour Growth Top 50…
startupticker.ch
-
BioVersys to go public at SIX Swiss Exchange
BioVersys develops novel antibacterial products for serious life-threatening infections caused by multidrug-resistant bacteria. The Basel-based company plans to conduct an initial public offering on the…
startupticker.ch
-
Swiss startups strengthen presence in North America
With the establishment of their new offices in the US, Attolight, Blocksport and NewBiologix, aim to increase proximity to customers in the North American market,…
startupticker.ch
-
RhyGaze raises USD 86 million to advance gene therapy for retinal diseases
Based in Basel and Philadelphia, USA, RhyGaze has secured a Series A financing of USD 86 million to enable clinical advancements for its lead candidate,…
startupticker.ch
-
Sygnum achieves unicorn status with USD 58m growth round
Global digital asset banking group Sygnum has raised a total of USD 58 million in its oversubscribed Strategic Growth Round, giving it a post-money valuation…
startupticker.ch
-
Windward Bio launches with $200 million Series A financing round
Founded by serial entrepreneur Luca Santarelli, Windward Bio has just launched with a $200 million capital injection. These funds will accelerate clinical advancements in programs…
startupticker.ch
-
ONWARD Medical wins first commercial customers in the US
With the first commercial sale of the ARC-EX System in the US, ONWARD Medical has reached a key milestone in its journey to provide innovative…
startupticker.ch
-
Numab raises additional CHF50 million
Numab Therapeutics, a clinical stage biotechnology company focusing on multi-specific antibodies in immunology and oncology, closed an oversubscribed CHF 50 million Series C extension, bringing…
startupticker.ch
-
Read more: Switzerland, Big Pharma’s Shopping CentreThe top pharmaceutical companies are very active in Switzerland, participating in large financing rounds and acquiring companies or drug candidates. In 2024, the global number…
-
Read more: Robots and the Swiss Tradition of Customer FocusFor Swiss robotics startups, customer success and investor success go hand in hand. In addition to outstanding technology, this requires a high degree of customer…
